These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9586757)

  • 1. The effect of intestinal permeability on pancreatic enzyme-induced enteropathy in the rat.
    Lloyd-Still JD; Uhing MR; Arango V; Fusaro A; Kimura RE
    J Pediatr Gastroenterol Nutr; 1998 May; 26(5):489-95. PubMed ID: 9586757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indomethacin and pancreatic enzymes synergistically damage intestine of rats.
    Kimura RE; Arango V; Lloyd-Still J
    Dig Dis Sci; 1998 Oct; 43(10):2322-32. PubMed ID: 9790472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.
    FitzSimmons SC; Burkhart GA; Borowitz D; Grand RJ; Hammerstrom T; Durie PR; Lloyd-Still JD; Lowenfels AB
    N Engl J Med; 1997 May; 336(18):1283-9. PubMed ID: 9113931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of high-dose ibuprofen and pancreatic enzymes on the intestine of the rat.
    Kimura RE; Dy SA; Uhing MR; Beno DW; Jiyamapa VA; Lloyd-Still JD
    J Pediatr Gastroenterol Nutr; 1999 Aug; 29(2):178-83. PubMed ID: 10435655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy.
    Stevens JC; Maguiness KM; Hollingsworth J; Heilman DK; Chong SK
    J Pediatr Gastroenterol Nutr; 1998 Jan; 26(1):80-4. PubMed ID: 9443125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathology of fibrosing colonopathy of cystic fibrosis: a study of 12 cases and review of the literature.
    Pawel BR; de Chadarévian JP; Franco ME
    Hum Pathol; 1997 Apr; 28(4):395-9. PubMed ID: 9104936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholic acid ameliorates ibuprofen-induced enteropathy in the rat.
    Lloyd-Still JD; Beno DW; Uhing MR; Jiyamapa-Serna VA; Kimura RE
    J Pediatr Gastroenterol Nutr; 2001 Mar; 32(3):270-3. PubMed ID: 11345174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is fibrosing colonopathy an immune mediated disease?
    Lee J; Ip W; Durie P
    Arch Dis Child; 1997 Jul; 77(1):66-70. PubMed ID: 9279159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrosing colonopathy in cystic fibrosis: results of a case-control study.
    Smyth RL; Ashby D; O'Hea U; Burrows E; Lewis P; van Velzen D; Dodge JA
    Lancet; 1995 Nov; 346(8985):1247-51. PubMed ID: 7475715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound studies of the intestinal wall in patients with cystic fibrosis.
    Pohl M; Krackhardt B; Posselt HG; Lembcke B
    J Pediatr Gastroenterol Nutr; 1997 Sep; 25(3):317-20. PubMed ID: 9285384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic enzymes and fibrosing colonopathy.
    Bakowski M
    Lancet; 1999 Jul; 354(9174):249; author reply 251. PubMed ID: 10421321
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative and experimental pathology of fibrosing colonopathy.
    van Velzen D; Ball LM; Dezfulian AR; Southgate A; Howard CV
    Postgrad Med J; 1996 Mar; 72 Suppl 2():S39-48; discussion S49-51. PubMed ID: 8869182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrosing colonopathy in children with cystic fibrosis.
    Reichard KW; Vinocur CD; Franco M; Crisci KL; Flick JA; Billmire DF; Schidlow DV; Weintraub WH
    J Pediatr Surg; 1997 Feb; 32(2):237-41; discussion 241-2. PubMed ID: 9044129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrosing colonopathy in an adult cystic fibrosis patient after discontinuing pancreatic enzyme therapy.
    Mack EH; Brett AS; Brown D
    South Med J; 2004 Sep; 97(9):901-4. PubMed ID: 15455984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of pancreatic growth and of GP-2 content in the reserpinized rat model of cystic fibrosis.
    Leblond FA; Morisset J; LeBel D
    Pediatr Res; 1989 May; 25(5):478-81. PubMed ID: 2717264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystic fibrosis-associated colitis and fibrosing colonopathy.
    Schwarzenberg SJ; Wielinski CL; Shamieh I; Carpenter BL; Jessurun J; Weisdorf SA; Warwick WJ; Sharp HL
    J Pediatr; 1995 Oct; 127(4):565-70. PubMed ID: 7562277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of indomethacin and nimesulide, a selective cyclooxygenase-2 inhibitor, on key pathophysiologic steps in the pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in the rat.
    Sigthorsson G; Jacob M; Wrigglesworth J; Somasundaram S; Tavares I; Foster R; Roseth A; Rafi S; Mahmud T; Simpson R; Bjarnason I
    Scand J Gastroenterol; 1998 Jul; 33(7):728-35. PubMed ID: 9712237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrosing colonopathy in children with cystic fibrosis.
    Postgrad Med J; 1996 Mar; 72 Suppl 2():S11-29. PubMed ID: 8869179
    [No Abstract]   [Full Text] [Related]  

  • 19. Cystic fibrosis colonopathy.
    Lloyd-Still JD; Beno DW; Kimura RM
    Curr Gastroenterol Rep; 1999 Jun; 1(3):231-7. PubMed ID: 10980955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of fibrosing colonopathy: the role of methacrylic acid copolymer.
    Prescott P; Bakowski MT
    Pharmacoepidemiol Drug Saf; 1999 Oct; 8(6):377-84. PubMed ID: 15073899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.